OATP1B3-1B7 (LST-3TM12) Is a Drug Transporter That Affects Endoplasmic Reticulum Access and the Metabolism of Ezetimibe

MLA

Henriette E. Meyer zu Schwabedissen, et al. “OATP1B3-1B7 (LST-3TM12) Is a Drug Transporter That Affects Endoplasmic Reticulum Access and the Metabolism of Ezetimibe.” Molecular Pharmacology, vol. 96, no. 2, Oct. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d5f0ed6523cd8d373a5a53ae65a2dd91&authtype=sso&custid=ns315887.

APA

Henriette E. Meyer zu Schwabedissen, Isabell Seibert, Stephan Krähenbühl, Urs Duthaler, & Vanessa Malagnino. (2018). OATP1B3-1B7 (LST-3TM12) Is a Drug Transporter That Affects Endoplasmic Reticulum Access and the Metabolism of Ezetimibe. Molecular Pharmacology, 96(2).

Chicago

Henriette E. Meyer zu Schwabedissen, Isabell Seibert, Stephan Krähenbühl, Urs Duthaler, and Vanessa Malagnino. 2018. “OATP1B3-1B7 (LST-3TM12) Is a Drug Transporter That Affects Endoplasmic Reticulum Access and the Metabolism of Ezetimibe.” Molecular Pharmacology 96 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d5f0ed6523cd8d373a5a53ae65a2dd91&authtype=sso&custid=ns315887.